Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

National Marrow Donor Program Long-Term Donor Follow-Up

ClinicalTrials.gov ID: NCT01362179

Public ClinicalTrials.gov record NCT01362179. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 9:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Incidence of Hematologic and Non-Hematologic Malignancies, Thrombotic Events, and Autoimmune Disorders in Unrelated Normal Donors Undergoing Bone Marrow Harvest Versus Peripheral Blood Stem Cell Mobilization With Recombinant Human Granulocyte Colony-Stimulating Factor (rHuG-CSF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an observational study of unstimulated bone marrow (BM) and filgrastim-mobilized peripheral blood stem cell (PBSC) donors. The primary goal is to evaluate the hypothesis that the incidence of targeted malignant, thrombotic and autoimmune disorders after unrelated hematopoietic stem cell donation are similar between unstimulated BM and filgrastim-mobilized PBSC donors.

Study identification

NCT ID
NCT01362179
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
21,974 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2010 (Type not available)
Primary completion
Sep 30, 2020 (Actual)
Completion
Oct 15, 2020 (Actual)
Last update posted
Oct 20, 2020

2010 – 2020

United States locations

U.S. sites
28
U.S. states
19
U.S. cities
28
Facility City State ZIP Site status
City of Hope Duarte California 91010-3012 —
National Marrow Donor Program Northern California & Northwest District Oakland California 94612 —
National Marrow Donor Program Southern California & Southwest District Santa Ana California 92705 —
Colorado Marrow Donor Program Denver Colorado 80230-6918 —
OneBlood Fort Lauderdale Florida 33309 —
Hawaii Bone Marrow Donor Registry Honolulu Hawaii 96817-1651 —
LifeSource Glenview Illinois 60025-2498 —
Rock River Valley Blood Center Rockford Illinois 61107 —
Indiana Blood Center Indianapolis Indiana 46208-4437 —
National Marrow Donor Program Southcentral District, Heart of America Leawood Kansas 66206 —
Dana-Farber Cancer Institute Boston Massachusetts 02115-6013 —
Michigan Blood Grand Rapids Michigan 49503 —
The HLA Registry Oradell New Jersey 07649 —
New York Blood Center Brooklyn New York 11201 —
DKMS Americas New York New York 10016 —
National Marrow Donor Program Southeast District Charlotte North Carolina 28269 —
National Marrow Donor Program Northcentral District Cleveland Ohio 44131 —
Oklahoma Blood Institute Oklahoma City Oklahoma 73104-3251 —
National Marrow Donor Program Northeast District Philadelphia Pennsylvania 19123-3594 —
Rhode Island Blood Center Providence Rhode Island 02908-4811 —
Blood Assurance, Inc. Chattanooga Tennessee 37403-1207 —
Cooperative Appalachian Marrow Program Medic Regional Blood Center Knoxville Tennessee 37601 —
Baylor Research Institute Dallas Texas 75246-2029 —
Cook Children's El Paso Texas 79913 —
Gulf Coast Regional Blood Center Houston Texas 77054-1802 —
South Texas Blood and Tissue Center San Antonio Texas 78201-2023 —
Scott & White Clinic Temple Texas 76508-0001 —
Community Blood Center, Inc. Appleton Wisconsin 54914-9106 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01362179, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2020 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01362179 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →